A multiparametric pharmacogenomic strategy for drug repositioning predicts therapeutic efficacy for glioblastoma cell lines.
Shah AH, Suter R, Gudoor P, Doucet-O'Hare TT, Stathias V, Cajigas I, de la Fuente M, Govindarajan V, Morell AA, Eichberg DG, Luther E, Lu VM, Heiss J, Komotar RJ, Ivan ME, Schurer S, Gilbert MR, Ayad NG.
Shah AH, et al. Among authors: govindarajan v.
Neurooncol Adv. 2021 Dec 31;4(1):vdab192. doi: 10.1093/noajnl/vdab192. eCollection 2022 Jan-Dec.
Neurooncol Adv. 2021.
PMID: 35118385
Free PMC article.